Creon in HIV Patients With Steatorrhea
NCT00623025 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2011-08-01
Summary
The study investigates the effect of pancreatic enzymes on steatorrhea in HIV patients.
Conditions
- Steatorrhea
Interventions
- DRUG
-
Creon 25000
6 to 9 capsules Creon 25000 per day
- DRUG
-
6 to 9 capsules placebo per day
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Suntje Sander, PhD · Abbott
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2009-08-31
- Completion
- 2009-08-31
Countries
- Romania
Study Locations
More Related Trials
-
Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy
NCT02684591 ·Status: COMPLETED ·Phase: PHASE2
-
Lactate Metabolism Study in HIV Infected Persons
NCT00202228 ·Status: COMPLETED ·Phase: PHASE4
-
Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV
NCT01709448 ·Status: UNKNOWN
-
CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)
NCT02652546 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Study of the Patterns of Cellular Gene Expression in HIV-1 Patients Following Clinical Events Which Increase Plasma Virus Concentrations
NCT00001681 ·Status: COMPLETED
-
The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection
NCT05652088 ·Status: RECRUITING ·Phase: NA
-
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
NCT06113003 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
NCT05419024 ·Status: RECRUITING ·Phase: PHASE2
-
Vitamin E for NASH Treatment in HIV Infected Individuals
NCT03669133 ·Status: TERMINATED ·Phase: PHASE2
-
Prevalence of Advanced Fibrosis in Patients Living With HIV
NCT04066608 ·Status: ENROLLING_BY_INVITATION
-
Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons
NCT00889577 ·Status: COMPLETED
-
Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
NCT00119405 ·Status: COMPLETED
-
A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth
NCT00069004 ·Status: COMPLETED
-
Enteropathy and Diabetes in HIV Patients
NCT03713502 ·Status: UNKNOWN
-
Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans
NCT02154035 ·Status: COMPLETED
-
Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy
NCT01976715 ·Status: COMPLETED
-
Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs
NCT00006290 ·Status: COMPLETED
-
Impact of SBI, a Medical Food, on Nutritional Status in Patients With HIV-associated Enteropathy
NCT01828593 ·Status: COMPLETED ·Phase: NA
-
Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
NCT00130286 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV
NCT05630885 ·Status: COMPLETED ·Phase: PHASE2
-
The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism
NCT00259727 ·Status: COMPLETED
-
Statin Therapy to Improve Atherosclerosis in HIV Patients
NCT00965185 ·Status: COMPLETED ·Phase: NA
-
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
NCT04795219 ·Status: ACTIVE_NOT_RECRUITING
-
Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 Percent
NCT00002029 ·Status: COMPLETED ·Phase: NA
-
Cardiometabolic Effects of Eplerenone in HIV Infection
NCT02629094 ·Status: TERMINATED ·Phase: PHASE2